新股首日 | “穿刺手术机器人第一股”真健康医疗-B(02697)首挂上市 早盘高开159.27%

智通财经
Jun 30

智通财经APP获悉,真健康医疗-B(02697)首挂上市,公告显示,每股定价126.2港元,共发行356.47万股股份,每手20股,所得款项净额约3.84亿港元。截至发稿,涨159.27%,报327.2港元,成交额1.69亿港元。

公开资料显示,真健康医疗于中国从事经皮穿刺手术及消融手术机器人研发及商业化。公司拥有一款核心产品,为经皮穿刺手术机器人,共有四个型号,即TH-S1、TH-S、TH-SPro及TH-SA。其中,TH-S1、TH-S、TH-SPro及TH-SA均已获得国家药监局颁发的三类注册证,其获准应用于肺部及腹部穿刺;公司正在将TH-S1的适应症扩展至腹膜后病变。

根据灼识咨询资料,真健康医疗2025年共交付六套设备,按出货量计市场份额36.4%,位居全国首位。得益于手术机器人设备交付量提升,公司收入由2024年的179.1万元人民币增加至2025年的1217.8万元人民币。另据公开资料,真健康医疗相关产品已进入全国近100家医疗机构,完成手术逾7200例,涵盖穿刺活检、术前定位、肿瘤消融、粒子植入等广泛术式,这些数据反映出其产品在多类型医疗场景中的临床应用价值与市场认可度。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10